Timing of Antidepressant Discontinuation During Pregnancy and Postpartum Psychiatric Outcomes in Denmark and Norway.


Journal

JAMA psychiatry
ISSN: 2168-6238
Titre abrégé: JAMA Psychiatry
Pays: United States
ID NLM: 101589550

Informations de publication

Date de publication:
01 05 2023
Historique:
medline: 5 5 2023
pubmed: 9 3 2023
entrez: 8 3 2023
Statut: ppublish

Résumé

Approximately one-half of women treated for affective disorders discontinue antidepressant use during pregnancy, yet this discontinuation could lead to relapse post partum. To investigate the associations between longitudinal antidepressant fill trajectories during pregnancy and postpartum psychiatric outcomes. This cohort study used nationwide registers in Denmark and Norway. The sample included 41 475 live-born singleton pregnancies in Denmark (1997-2016) and 16 459 in Norway (2009-2018) for women who filled at least 1 antidepressant prescription within 6 months before pregnancy. Antidepressant prescription fills were obtained from the prescription registers. Antidepressant treatment during pregnancy was modeled using the k-means longitudinal method. Initiation of psycholeptics, psychiatric emergencies, or records of self-harm within 1 year post partum. Between April 1 and October 30, 2022, hazard ratios (HRs) for each psychiatric outcome were estimated using Cox proportional hazards regression models. Inverse probability of treatment weighting was used to control for confounding. Country-specific HRs were pooled using random-effects meta-analytic models. Among 57 934 pregnancies (mean [SD] maternal age, 30.7 [5.3] years in Denmark and 29.9 [5.5] years in Norway), 4 antidepressant fill trajectories were identified: early discontinuers (31.3% and 30.4% of the included pregnancies in Denmark and Norway, respectively), late discontinuers (previously stable users) (21.5% and 27.8%), late discontinuers (short-term users) (15.9% and 18.4%), and continuers (31.3% and 23.4%). Early discontinuers and late discontinuers (short-term users) had a lower probability of initiating psycholeptics and having postpartum psychiatric emergencies vs continuers. A moderately increased probability of initiation of psycholeptics was found among late discontinuers (previously stable users) vs continuers (HR, 1.13; 95% CI, 1.03-1.24). This increase in late discontinuers (previously stable users) was more pronounced among women with previous affective disorders (HR, 1.28; 95% CI, 1.12-1.46). No association between antidepressant fill trajectories and postpartum self-harm risk was found. Based on pooled data from Denmark and Norway, a moderately elevated probability of initiation of psycholeptics in late discontinuers (previously stable users) vs continuers was found. These findings suggest that women with severe mental illness who are currently on stable treatment may benefit from continuing antidepressant treatment and personalized treatment counseling during pregnancy.

Identifiants

pubmed: 36884236
pii: 2802141
doi: 10.1001/jamapsychiatry.2023.0041
pmc: PMC9996461
doi:

Substances chimiques

Antidepressive Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

441-450

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH122869
Pays : United States

Références

J Affect Disord. 2015 Jul 15;180:179-84
pubmed: 25911132
Basic Clin Pharmacol Toxicol. 2010 Feb;106(2):86-94
pubmed: 19961477
PLoS Med. 2022 Jan 31;19(1):e1003895
pubmed: 35100270
Best Pract Res Clin Obstet Gynaecol. 2014 Jan;28(1):3-12
pubmed: 24140480
Eur J Epidemiol. 2018 Jan;33(1):27-36
pubmed: 29349587
J Affect Disord. 2022 Jul 1;308:458-465
pubmed: 35461816
Am J Psychiatry. 2016 Jun 1;173(6):635-42
pubmed: 26940804
Pharmacoepidemiol Drug Saf. 2015 Sep;24(9):934-42
pubmed: 26045370
J Matern Fetal Neonatal Med. 2017 May;30(10):1129-1132
pubmed: 27334426
J Psychopharmacol. 2015 May;29(5):459-525
pubmed: 25969470
Scand J Public Health. 2011 Jul;39(7 Suppl):38-41
pubmed: 21775349
Clin Epidemiol. 2013 Nov 01;5(Suppl 1):39-46
pubmed: 24227922
J Clin Psychiatry. 2020 Jun 9;81(4):
pubmed: 32558401
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
J Clin Psychiatry. 2013 Apr;74(4):e321-41
pubmed: 23656857
Arch Womens Ment Health. 2018 Aug;21(4):411-419
pubmed: 29340802
Lancet Psychiatry. 2017 Jun;4(6):477-485
pubmed: 28476427
Clin Obstet Gynecol. 2009 Sep;52(3):469-82
pubmed: 19661762
Epidemiology. 2011 Nov;22(6):848-54
pubmed: 21900825
Scand J Public Health. 2011 Jul;39(7 Suppl):95-8
pubmed: 21775363
World Psychiatry. 2014 Feb;13(1):56-67
pubmed: 24497254
Arch Womens Ment Health. 2005 Nov;8(4):214-20
pubmed: 15959622
JAMA Netw Open. 2021 Dec 1;4(12):e2136639
pubmed: 34851402
Arch Gen Psychiatry. 2008 Jul;65(7):805-15
pubmed: 18606953
Acta Obstet Gynecol Scand. 2000 Jun;79(6):435-9
pubmed: 10857866
Br J Psychiatry. 2016 May;208(5):462-9
pubmed: 26494874
Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1131-1138
pubmed: 29664233
Acta Obstet Gynecol Scand. 2014 Feb;93(2):132-7
pubmed: 24237585
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
JAMA. 2006 Feb 1;295(5):499-507
pubmed: 16449615
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
Stat Med. 2015 Dec 10;34(28):3661-79
pubmed: 26238958
Epidemiol Rev. 2022 Jan 14;43(1):130-146
pubmed: 34100086
Acta Obstet Gynecol Scand. 1999 Apr;78(4):305-9
pubmed: 10203297
Scand J Public Health. 2011 Jul;39(7 Suppl):22-5
pubmed: 21775345
BMC Med Inform Decis Mak. 2015 Mar 25;15:21
pubmed: 25890003

Auteurs

Nhung T H Trinh (NTH)

PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, Oslo, Norway.

Trine Munk-Olsen (T)

NCRR-The National Centre for Register-based Research, Aarhus University, Aarhus, Denmark.
Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Naomi R Wray (NR)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia.

Veerle Bergink (V)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.
Department of Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands.

Hedvig M E Nordeng (HME)

PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, Oslo, Norway.
Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway.

Angela Lupattelli (A)

PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, Oslo, Norway.

Xiaoqin Liu (X)

NCRR-The National Centre for Register-based Research, Aarhus University, Aarhus, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH